Skip to main content

Table 5 PCR-corrected treatment responses in the PP population according to age.

From: Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria

Age group

ASAQ1

(N = 283)

ASAQ2

(N = 285)

AL

(N = 289)

Total

(N = 857)

< 5 years

132/134

(98.5%)

137/137

(100%)

129/133

(97.0%)

398/404

(98.5%)

5 – 14 years

97/98

(99.0%)

106/106

(100%)

106/106

(100%)

309/310

(99.7%)

≥ 14 years

51/51

(100%)

42/42

(100%)

50/50

(100%)

143/143

(100%)